These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3726063

  • 21. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S.
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [Abstract] [Full Text] [Related]

  • 22. Psychopharmacology of the anxiety disorders.
    Ballenger JC.
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [Abstract] [Full Text] [Related]

  • 23. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 24. [Antidepressive agents in the treatment of agoraphobia and panic--an evaluative review].
    Ost LG.
    Lakartidningen; 1986 Oct 08; 83(41):3421-2, 3424-5. PubMed ID: 3537591
    [No Abstract] [Full Text] [Related]

  • 25. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R, Reich J, Clancy J, O'Gorman TW.
    Br J Psychiatry; 1986 Nov 08; 149():631-5. PubMed ID: 3814956
    [Abstract] [Full Text] [Related]

  • 26. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D.
    Am J Psychiatry; 1989 Jul 08; 146(7):922-4. PubMed ID: 2742019
    [Abstract] [Full Text] [Related]

  • 27. Alprazolam-induced manic reaction.
    Mayerhoff D, Vital-Herne J, Lesser M, Brenner R.
    N Y State J Med; 1986 Jun 08; 86(6):320. PubMed ID: 2874537
    [No Abstract] [Full Text] [Related]

  • 28. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May 08; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 29. Serotonin antagonism in panic disorder: an open trial with ritanserin.
    Griez E, Pols H, Lousberg H.
    Acta Psychiatr Belg; 1988 May 08; 88(5-6):372-7. PubMed ID: 3152708
    [Abstract] [Full Text] [Related]

  • 30. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 May 08; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 31. Recent developments in the understanding and pharmacotherapy of panic attacks.
    Liebowitz MR, Fyer AJ, Gorman J, Klein DF.
    Psychopharmacol Bull; 1986 May 08; 22(3):792-6. PubMed ID: 3797584
    [No Abstract] [Full Text] [Related]

  • 32. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct 08; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 33. Lorazepam vs. alprazolam in the treatment of panic disorder.
    Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani VK.
    Pharmacopsychiatry; 1990 Mar 08; 23(2):90-3. PubMed ID: 2187213
    [Abstract] [Full Text] [Related]

  • 34. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC, Garcia-Sevilla JA, Cameron OG, Smith CB.
    Biol Psychiatry; 1982 Jun 08; 17(6):761-6. PubMed ID: 6285996
    [No Abstract] [Full Text] [Related]

  • 35. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov 08; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

  • 36. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB, Brotman AW, Rosenbaum JF.
    J Clin Psychiatry; 1987 Oct 08; 48 Suppl():22-8. PubMed ID: 2889722
    [Abstract] [Full Text] [Related]

  • 37. Continuation treatment of panic disorder with high-potency benzodiazepines.
    Davidson JR.
    J Clin Psychiatry; 1990 Dec 08; 51 Suppl A():31-7. PubMed ID: 2258375
    [Abstract] [Full Text] [Related]

  • 38. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779
    [Abstract] [Full Text] [Related]

  • 39. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
    Lopez AL, Kathol RG, Noyes R.
    Psychoneuroendocrinology; 1990 Nov 01; 15(1):23-8. PubMed ID: 2367614
    [Abstract] [Full Text] [Related]

  • 40. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
    Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J.
    J Clin Psychopharmacol; 1983 Feb 01; 3(1):28-31. PubMed ID: 6403599
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.